NEC OncoImmunity Acquires VAXIMM’s Neoantigen Vaccine Development Assets
OSR Holdings Reg No. 589-86-01485
Email. group@osr-holdings.com
B-dong, 3F, 37-36 Hoedong-gil, Paju-si, Gyeonggi-do
Copyright © OSR Holdings.Co.,Ltd. All Rights Reserved.
OSR Holdings Reg No. 589-86-01485 Email. group@osr-holdings.com
B-dong, 3F, 37-36 Hoedong-gil, Paju-si, Gyeonggi-do
Copyright © OSR Holdings.Co.,Ltd. All Rights Reserved.
OSR Holdings, an Open and Socially Responsible Healthcare Group
https://www.naver.com/